With big pharma leaning on external pipelines, the company sees opportunity in de-risked, high-impact assets with clear clinical endpoints
_256_384.png)
The company plans a phased expansion across India, focusing initially on metro cities and early-adoption hubs
The company has supported the initiative since its inception, contributing to screening efforts in around 120 countries
New acetabular system enhances precision, stability and robotic compatibility in total hip arthroplasty
The company reported consolidated total income of Rs. 161.3 crore in Q4 FY26, a strong jump from Rs. 120.3 crore in the same period last year
New home-use glucometer delivers results in under 10 seconds with simplified testing, large memory storage, and user-friendly design
In his new role, Gregory will drive partnerships for the company’s large-scale molecule biologics business across Europe
The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities
Hyderabad based 400-bed facility brings AI-driven care, advanced imaging, and integrated clinical systems under one roof
Ajax's lead program, AJ1-11095, is a first-in-class Type II JAK2 inhibitor currently in Phase 1 clinical development, with first proof-of-concept clinical data to be presented later in 2026
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
